课题基金 / 基金详情

Epigenetic priming of neuroblastoma to Natural Killer cell-based immunotherapy

Epigenetic priming of neuroblastoma to Natural Killer cell-based immunotherapy
神经母细胞瘤对基于自然杀伤细胞的免疫疗法的表观遗传启动
批准号：
489370
负责人：
Raynal Noël J
金额：
$59.07万
依托单位：
Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2028-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=489370&lang=en
关键词：
3d Cell Culture Epigenetics Neuroblastoma Nk Cells

项目摘要

项目成果

Raynal Noël J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neuroblastoma is the most common extracranial solid tumour in children. Neuroblastoma arises from nerve cells, most often in the adrenal glands, or in other areas of the abdomen, the chest, the neck, and near the spine. Despite intensive treatments (surge
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modelling cell dynamics and epigenetic changes in 3D spheroids with custom-made hydrogels
Epigenetic priming of neuroblastoma to NK cell-based immunotherapy
4D spheroids identify type I protein arginine methyltransferases as a target in NSCLC
海外基金